TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Infrarenal aneurysm's neck growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Changes in appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraindividual changes in sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Intraindividual changes in average glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effect of sleep restriction condition on insulin resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bronchoalveolar lavage fluid (BALF) levels of IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional Communication
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of early infusion-related events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of late clinical reactions to EBV Tscm-CTLs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in WHO-5 (WHO-Five Well-being Index)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in SDQ (Strengths and Difficulties Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total specific anti-SARS-CoV-2 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutralizing anti-SARS-CoV-2 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Skill performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Usefulness, Satisfaction, and Ease of Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Children's Emotional Manifestation Scale (CEMS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Motility of ocular prosthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in microbial analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of VOUS reclassified as pathogenic or benign
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage bleeding on probing (BOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and acute toxicity of chlorpromazine
Endpoint domain: Adverse events/effects
Primary endpoint: Upper Extremity manual dexterity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wolf motor function test (WMFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective drug ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline 10 meter walk test (10-MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety evaluation of mRNA HBV/TCR T-cell treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Modifications of tumour microenvironment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction of consumed analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in self-stigma of age
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in self-stigma of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants who Experienced at least one Treatment-Emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Placebo- and Baseline-Corrected QTcF (ΔΔQTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Differentiation of sub-types of low grade glioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lower Extremity Function Scale (LEFS) change from baseline
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Minimal Clinically Important Difference (MCID) for LEFS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Outcome of levator muscle resection and plication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency of P1 waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pharmacokinetics of GP681
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety evaluation of GP681
Endpoint domain: Adverse events/effects
Primary endpoint: Brachial artery Flow Mediated Dilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time for daily use of CPAP therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in reward sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average amount of blood collected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Falls Efficacy Scale - International (FES-I)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline Fugl-Meyer Assessment - Upper Extremity (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antitumor activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Response of breast cancer to neoadjuvant chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: change PYY
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: change GLP-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of death
Endpoint domain: Mortality/survival
Primary endpoint: Quantification of circulating (blood) (poly)phenols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Quantification of urinary (poly)phenols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: RR interval (seconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Qualitative distinction of P-waves, QRS-complexes, T-waves, and noise levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Local-Regional Control Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: change in single leg support time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in temporal and spatial symmetry index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of a subpopulation of circulating neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ulcer evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent donor chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Negative Replication Competent Lentivirus (RCL)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of electrical spinal cord stimulation
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life related to MS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adenovirus infection
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of detrusor muscle in the resected sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBA1c (Glycated hemoglobin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-year recurrence and metastasis rate
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Participants with Documented On-Site Blood Pressure, Height, and Weight Recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Newly-Diagnosed Hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Newly-Diagnosed Diabetes Mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Health Care Providers Pain and Impairment Relationship Scale (HC-PAIRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fractional absorption of iron (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in symptomatology of Long COVID
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in plasma D-Dimer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment Emergent Adverse Events Following Single Doses
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinical Laboratory Abnormalities Following Single Doses
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Change in Baseline Vital Signs Following Single Doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Glaucoma Symptom Score (GSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in cognitive function on WISC-IV
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change in functional capacity on six minutes walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in gross motor function on GMFM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recalling capacity of stroke symptoms
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Area under the concentration versus time curve from zero to infinity of BAY1747846 after single dose administration (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed drug concentration of BAY1747846 in plasma after single dose administration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total body clearance of BAY1747846 normalized by body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Present Pain Intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the width of the keratinized gingiva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in the thickness of the keratinized gingiva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from Baseline Appendicular skeletal muscle mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue Penetration of Tebipenem Pivoxil Hydrobromide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleeping Metabolic Rate (SMR) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Appliance failure
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Colonic transit time during 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Colonic transit time during 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: symptomatic UTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: myoton
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dolorimeter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in muscle quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Distribution of Non-Ceruloplasmin bound Copper (NCC) in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients with preoperative full stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Type of content presented in preoperative full stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent of total distribution of ventilation by region
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: survival rate of teeth restored
Endpoint domain: Mortality/survival
Primary endpoint: number of failed crowns
Endpoint domain: Adverse events/effects
Primary endpoint: Number of cell groups expressing different markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of cell groups expressing different markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: recurrent rate of GI bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Locally Relapsed Rate (LRRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Functional capacity assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Visiospatial perception
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Bacterial colonization in the skin under dressing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Concordance between smartwatch application and clinical assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in situational state of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preoperative Anxiety Level-1
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preoperative Anxiety Level-2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total ultrasound competence score at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ultrasound competence score after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Point-of-care (POC) HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Articular step-off of the distal radius joint surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Articular gap of the distal radius joint surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: F0 (Fundamental Frequency)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jitter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NHR (Noise to Harmonic Ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ATRI (Amplitude Tremor Intensity Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of cfDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 18F-LN1 and 18F-FDG uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Respiratory cortical and spinal drive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Maximum respiratory voluntary force production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Forced vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean Change from Baseline in Dental Caries Lesions using ICDAS score at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Mean Change from Baseline in Dental Caries Lesions using dmfs index at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Change from Baseline in Dental Caries Activity using Arrested or Active caries characteristics at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Mean Change from Baseline in Dental Caries Susceptibility using the CariScreen Caries Susceptibility Testing meter at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Healing of periradicular lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Major wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Unified Myoclonus Rating Scale (UMRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in speech output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of third generation cephalosporin-resistant bacteria
Endpoint domain: Adverse events/effects
Primary endpoint: Complete Remission Rate of Proteinuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change of time in range (TIR) 70-180 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DSA-related contrast media use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total procedural contrast media use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Image quality, graded by independent observers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower limbs muscle power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Assessment of erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: shoulder pain changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: knee pain changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: range of motion changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: muscle tone changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Days Alive Out of Hospital
Endpoint domain: Mortality/survival
Primary endpoint: Score change of McGill QOL-Hong Kong
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Resolution of hemoptysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: cumulative amount of opioids used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: the quality of recovery after the operation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional connectivity during resting state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mu-opioid receptor binding capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of ocular biometrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in rod-intercept time (RIT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of any treatment-emergent adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the concentration-time curve of BI 1815368 in plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of BI 1815368 in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma metabolite content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: size of the niche post operatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Readiness to change composite score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fear and Avoidance of Memory Loss (FAM) Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fear of Alzheimer's Disease Scale (FADS) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in CIN1 regression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cognition Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain-derived neurotrophic factor (BDNF) Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement with intervention method
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Incidence of post-thoracotomy pain syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinical laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Becks Depression Inventory-II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Generalised Anxiety Disorder 7-item scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neuropsychiatric Inventory- Brief Questionnaire Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall symptom relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Plasma Concentration-time Profile (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes